Filtered By:
Infectious Disease: Coronavirus
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 2387 results found since Jan 2013.
New Presentation of CD27 Deficiency; Coronary Ectasia and COVID-19
Iran J Allergy Asthma Immunol. 2023 Feb 20;22(1):110-118. doi: 10.18502/ijaai.v22i1.12013.ABSTRACTCD27 is a costimulatory receptor involved in the maturation of the innate and adaptive immunity. CD27, through interaction with CD70, plays a role in the control of Epstein-Barr virus (EBV) infection. CD27 deficiency leads to an immune dysregulation disease characterized by EBV susceptibility. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might put patients with primary immunodeficiency at risk for adverse outcomes. Chromogenic in situ hybridization (CISH) study was performed to detect EBV in the lymphoma tissue...
Source: Iranian Journal of Allergy, Asthma and Immunology - April 1, 2023 Category: Allergy & Immunology Authors: Zahra Golchehre Samin Sharafian Nader Momtazmanesh Zahra Chavoshzadeh Abdollah Karimi Hassan Abolhassani Maryam Kazemi Aghdam Koroush Vahidshahi Seyedehatefeh Hashemimoghaddam Farid Kosari Zahra Khafafpour Bibi Shahin Shamsian Mohammad Keramatipour Source Type: research
Type 2 inflammation reduces SARS-CoV-2 replication in the airway epithelium in allergic asthma through functional alteration of ciliated epithelial cells
Despite well-known susceptibilities to other respiratory viral infections, individuals with allergic asthma have shown reduced susceptibility to severe coronavirus disease 2019 (COVID-19).
Source: Journal of Allergy and Clinical Immunology - March 29, 2023 Category: Allergy & Immunology Authors: Naresh Doni Jayavelu, Matthew C. Altman, Basilin Benson, Matthew J. Dufort, Elizabeth R. Vanderwall, Lucille M. Rich, Maria P. White, Patrice M. Becker, Alkis Togias, Daniel J. Jackson, Jason S. Debley Source Type: research
Asymptomatic surveillance testing for COVID-19 in health care professional students: lessons learned from a low prevalence setting
The novel coronavirus disease of 2019 (COVID-19) pandemic has severely impacted the training of health care professional students because of concerns of potential asymptomatic transmission to colleagues and vu...
Source: Allergy, Asthma and Clinical Immunology - March 29, 2023 Category: Allergy & Immunology Authors: Alyssa G. Burrows, Sophia Linton, Jenny Thiele, Prameet M. Sheth, Gerald A. Evans, Stephen Archer, Katharine M. Doliszny, Marcia Finlayson, Leslie Flynn, Yun Huang, Azim Kasmani, T. Hugh Guan, Allison Maier, Adrienne Hansen-Taugher, Kieran Moore, Anthony Tags: Short report Source Type: research
The role of interleukin 13 and the type 2 immune pathway in COVID-19
Although much has been learned about severe acute respiratory syndrome coronavirus 2 since December 2019, uneven global vaccine distribution, rapid viral spread, and variant evasion of preventative measures have led to its persistence in the population for the foreseeable future. Additional therapies are needed to support patients through their acute, immune-mediated disease process that continues to lead to considerable morbidity and mortality. Data revealing the involvement of type 2 immune pathway in acute coronavirus disease 2019 and post-recovery conditions represent a potential additional area for intervention.
Source: Annals of Allergy, Asthma and Immunology - March 14, 2023 Category: Allergy & Immunology Authors: Jennifer Sasson, G. Brett Moreau, William A. Petri Tags: Review Source Type: research
The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review
Although much has been learned about severe acute respiratory syndrome coronavirus 2 since December 2019, uneven global vaccine distribution, rapid viral spread, and variant evasion of preventative measures have led to its persistence in the population for the foreseeable future. Additional therapies are needed to support patients through their acute, immune-mediated disease process that continues to lead to considerable morbidity and mortality. Data revealing the involvement of type 2 immune pathway in acute coronavirus disease 2019 and post-recovery conditions represent a potential additional area for intervention.
Source: Annals of Allergy, Asthma and Immunology - March 14, 2023 Category: Allergy & Immunology Authors: Jennifer Sasson, G. Brett Moreau, William A. Petri Tags: Review Source Type: research
Science takes back seat to politics in first House hearing on origin of COVID-19 pandemic
Some scientists and legislators might have hoped this morning’s U.S. congressional hearing on the origin of the COVID-19 pandemic would move beyond partisan politics and seriously investigate what has become a
deeply divisive debate
. But members of the House of Representatives’s Select Subcommittee on the Coronavirus Pandemic mostly hammered home long-standing Republican or Democratic talking points, shedding no new light on the central question: Did SARS-CoV-2 naturally jump from animals to humans or did the virus somehow leak from a laboratory in Wuhan, China?
“It was very disappointing, and almost unbe...
Source: Science of Aging Knowledge Environment - March 8, 2023 Category: Geriatrics Source Type: research
